Female Condom Skill and Attitude: Results from a NIDA Clinical Trials Network Gender-Specific HIV Risk Reduction Study

Campbell, Aimee N.C.; Tross, Susan; Hu, Mei‐Chen; Pavlicová, Martina; Kenney, Jennifer L.; Nunes, Edward V.

doi:10.1521/aeap.2011.23.4.329

Cited by 17 publications

(19 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Individual-focused behavioral prevention approaches have included a number of core components such as skills building; negotiation of safer sex practices; promotion of condom use; serostatus knowledge and HIV testing; safety planning to deal with IPV; mental health; empowerment skills to help women access care, services, and employment [28,46,56–60]; and reducing PTSD symptoms [30,38]. Typically, these components are delivered in an individual or group modality and they were found to assist women in reducing sex and drug risks.…”

Section: Multilevel Hiv Preventionmentioning

confidence: 99%

Dual HIV risk and vulnerabilities among women who use or inject drugs

El‐Bassel

Wechsberg²,

Shaw³

2012

Current Opinion in HIV and AIDS

View full text Add to dashboard Cite

Purpose of review This article examines the dual HIV and sexually transmitted infection (STI) risk behaviors engaged in by women who use or inject drugs; the individual, social, and structural drivers of HIV and STI risk; prevention strategies; and the implications for multilevel, combined, sex-specific HIV prevention strategies. Recent findings Women who use or inject drugs, especially female sex workers, are at dual risk for HIV, the hepatitic C virus (HCV), and other STIs. In countries with HIV prevalence higher than 20% among injecting drug users (IDUs), female IDUs have slightly higher HIV prevalence than male IDUs. Women who use or inject drugs face multilevel drivers that increase their vulnerabilities to HIV, HCV, and STIs. Despite advances in behavioral HIV prevention strategies for this population, most prevention studies have not sufficiently targeted dyadic, social, and structural levels. Few recent advances in biomedical HIV prevention have focused on women who use drugs and their unique needs. Summary HIV prevention strategies and services need to address the unique and multilevel drivers that increase the vulnerabilities to HIV, HCV, and STIs among women who use drugs including those who engage in sex work. Scaling-up and improving access to multilevel and combined HIV prevention strategies for these women is central to combating the HIV epidemic.

show abstract

Section: Multilevel Hiv Preventionmentioning

confidence: 99%

Dual HIV risk and vulnerabilities among women who use or inject drugs

El‐Bassel

Wechsberg²,

Shaw³

2012

Current Opinion in HIV and AIDS

View full text Add to dashboard Cite

show abstract

“…Lawrence et al, 1995; Tross et al, 2008; Wechsberg et al, 2004). Although these interventions can produce substantial increases in knowledge/skills, increases in actual condom use are modest (Campbell et al, 2011; Meader et al, 2010; Prendergast et al, 2001; Semaan et al, 2002; Tross et al, 2008). The same is true for interventions targeting OD women specifically (e.g., Tross et al, 2008), suggesting that deficits in risk reduction knowledge/skills do not fully account for the high rates sexual HIV risk behavior observed among OD women.…”

Section: Introductionmentioning

confidence: 99%

Examining delay discounting of condom-protected sex among opioid-dependent women and non-drug-using control women

Herrmann

Hand

Johnson

et al. 2014

Drug and Alcohol Dependence

View full text Add to dashboard Cite

Background Opioid-dependent (OD) women tend to engage in unprotected sex with high-risk partners, placing themselves at elevated risk for sexually transmitted HIV infection. This behavior generally persists after completion of interventions that increase sexual HIV risk reduction knowledge and skills, suggesting that decision-making biases may influence HIV transmission among OD women. Methods The primary aim of this report is to examine delay discounting of condom-protected sex among OD women and non-drug-using control women using the novel Sexual Discounting Task (SDT; Johnson and Bruner, 2012). Data were collected from 27 OD women and 33 non-drug-using control women using the SDT, a monetary discounting task, and the Barratt Impulsiveness Scale (BIS-11). Results OD women discounted the value of delayed condom-protected sex more steeply than controls for hypothetical sexual partners in the two sets of paired partner conditions examined. Overall, women discounted condom protected sex more steeply for partners they perceived as being lowest STI risk vs. those they perceived as being highest risk. Steeper discounting of condomprotected sex was significantly associated with higher scores on the BIS-11, but not with discounting of money. Conclusions Delay discounting of condom-protected sex differs between OD women and non-drug-using women, is sensitive to perceived partner risk, and is correlated with a self-report measure of impulsivity, the BIS-11. The effect of delay on sexual decision-making is a critical but underappreciated dimension of HIV risk among women, and the SDT appears to be a promising measure of this domain. Further investigation of these relationships is warranted.

show abstract

“…Previous programs or interventions with messages highlighting the positive benefits of the FC (e.g., increased sexual pleasure and autonomy) may also increase uptake [3]. IPC interventions that include demonstrations can be critical in improving women’s comfort level with FCs and shift attitudes towards the FC [12]. Women report that the overall acceptability of the FC improves over time with practice [13–15].…”

Section: Discussionmentioning

confidence: 99%

Impact of communication strategies to increase knowledge, acceptability, and uptake of a new Woman’s Condom in urban Lusaka, Zambia: study protocol for a randomized controlled trial

Pinchoff

Chowdhuri²,

Taruberekera

et al. 2016

Trials

View full text Add to dashboard Cite

BackgroundGlobally, 220 million women experience an unmet need for family planning. A newly designed female condom, the Woman’s Condom (WC), has been developed featuring an improved design. It is the first dual-protection, female-initiated contraceptive that is a premium, higher price point product. However, market availability alone will not increase uptake. In February 2016 the WC will be distributed with a strong media campaign and interpersonal communication (IPC) outreach intervention. The impact of these on knowledge, acceptability, and use of the WC will be measured.Methods/designA baseline survey of 2314 randomly selected 18- to 24-year-old sexually active men and women has been conducted. The WC and mass media will be introduced throughout 40 urban wards in and surrounding Lusaka, Zambia. The baseline survey will serve as a quasi-control arm to determine the impact of introducing the WC with mass media. Half of the wards will be randomly allocated to additionally receive the IPC intervention. A single-blind randomized controlled trial will determine the impact of the IPC intervention on knowledge, uptake, and use of the WC. After one year, another 2314 individuals will be randomly selected to participate in the endline survey.We hypothesize that (1) the distribution and media campaign of the WC will increase overall condom use in selected urban wards, and specifically use of the WC; (2) the IPC intervention will significantly impact knowledge, acceptability, and use of the WC.The primary outcome measures are use of the WC, use of any condom, and willingness to use the WC. Secondary outcomes include measures of knowledge, acceptability, and choice of contraception.Odds ratios will be estimated to measure the effect of the intervention on the outcomes with 95% confidence intervals. All analyses will be based on the intention-to-treat principle.DiscussionIncreasing uptake of dual prevention measures (such as the WC) may reduce incidence of sexually transmitted infections/HIV and unplanned pregnancies. It is important to ensure young, urban adults have access to new contraceptive methods; and, understanding how mass media and IPC impact contraceptive knowledge, acceptability, and use is critical to reduce unmet need.Trial registration AEARCTR-0000899. Registered on 26 October 2015.Electronic supplementary materialThe online version of this article (doi:10.1186/s13063-016-1681-x) contains supplementary material, which is available to authorized users.

show abstract

Female Condom Skill and Attitude: Results from a NIDA Clinical Trials Network Gender-Specific HIV Risk Reduction Study

Cited by 17 publications

References 25 publications

Dual HIV risk and vulnerabilities among women who use or inject drugs

Dual HIV risk and vulnerabilities among women who use or inject drugs

Examining delay discounting of condom-protected sex among opioid-dependent women and non-drug-using control women

Impact of communication strategies to increase knowledge, acceptability, and uptake of a new Woman’s Condom in urban Lusaka, Zambia: study protocol for a randomized controlled trial

Contact Info

Product

Resources

About